Regions :: Western Europe :: Germany
Druggability signs collaboration agreement with Bayer HealthCare
5:43 AM MST | December 6, 2013 | Deepti Ramesh
Druggability Technologies (DRGT; Dublin) says it has entered into a multiyear collaboration agreement with Bayer HealthCare that will deploy DRGT's proprietary Super-API platform in support of Bayer HealthCare's formulation efforts directed at improving compound solubility and bioavailability. DRGT's platform will be applied from early compound screening to clinical formulation of candidate drugs. The platform is expected to be applied across a range of compounds that are burdened by low solubility and poor bioavailability. “We believe that the application...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee